BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32217757)

  • 1. Multifaceted effects of soluble human CD6 in experimental cancer models.
    Simões IT; Aranda F; Casadó-Llombart S; Velasco-de Andrés M; Català C; Álvarez P; Consuegra-Fernández M; Orta-Mascaró M; Merino R; Merino J; Alberola-Ila J; González-Aseguinolaza G; Carreras E; Martínez V; Lozano F
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of CD6 function through interaction with Galectin-1 and -3.
    Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
    FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
    Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
    J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
    Nair P; Melarkode R; Rajkumar D; Montero E
    Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6 modulates thymocyte selection and peripheral T cell homeostasis.
    Orta-Mascaró M; Consuegra-Fernández M; Carreras E; Roncagalli R; Carreras-Sureda A; Alvarez P; Girard L; Simões I; Martínez-Florensa M; Aranda F; Merino R; Martínez VG; Vicente R; Merino J; Sarukhan A; Malissen M; Malissen B; Lozano F
    J Exp Med; 2016 Jul; 213(8):1387-97. PubMed ID: 27377588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of CD6-mediated interactions in T cell activation and proliferation.
    Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
    J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
    Bowen MA; Aruffo AA; Bajorath J
    Proteins; 2000 Aug; 40(3):420-8. PubMed ID: 10861932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
    Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
    Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.
    Zimmerman AW; Joosten B; Torensma R; Parnes JR; van Leeuwen FN; Figdor CG
    Blood; 2006 Apr; 107(8):3212-20. PubMed ID: 16352806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic activated leukocyte cell adhesion molecule induces CD6
    Qian Q; Cui N; Huang B; Zhao Y; Liu Q; Hu M; Li B; Wang Q; Miao Q; You Z; Ma X; Tang R
    Front Immunol; 2022; 13():967944. PubMed ID: 36159854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated leucocyte cell adhesion molecule (ALCAM/CD166) regulates T cell responses in a murine model of food allergy.
    Kim YS; Kim MN; Lee KE; Hong JY; Oh MS; Kim SY; Kim KW; Sohn MH
    Clin Exp Immunol; 2018 May; 192(2):151-164. PubMed ID: 29363753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
    Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
    Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
    Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
    J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses.
    Carrasco E; Escoda-Ferran C; Climent N; Miró-Julià C; Simões IT; Martínez-Florensa M; Sarukhan A; Carreras E; Lozano F
    Front Immunol; 2017; 8():769. PubMed ID: 28713387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.
    Oliveira MI; Gonçalves CM; Pinto M; Fabre S; Santos AM; Lee SF; Castro MA; Nunes RJ; Barbosa RR; Parnes JR; Yu C; Davis SJ; Moreira A; Bismuth G; Carmo AM
    Eur J Immunol; 2012 Jan; 42(1):195-205. PubMed ID: 21956609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.
    Rambaldi B; Kim HT; Arihara Y; Asano T; Reynolds C; Manter M; Halpern M; Weber A; Koreth J; Cutler C; Gooptu M; Nikiforow S; Ho VT; Antin JH; Romee R; Ampudia J; Ng C; Connelly S; Soiffer RJ; Ritz J
    Haematologica; 2022 Nov; 107(11):2617-2629. PubMed ID: 35484649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution of CD6 and CD6 ligand in cattle: expression of the CD6 ligand (CD166) in the autonomic nervous system of cattle and the human.
    Konno A; Ahn JS; Kitamura H; Hamilton MJ; Gebe JA; Aruffo A; Davis WC
    J Leukoc Biol; 2001 Jun; 69(6):944-50. PubMed ID: 11404380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
    Hassan NJ; Barclay AN; Brown MH
    Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of a novel CD6 ligand in cells derived from joint and epithelial tissues.
    Saifullah MK; Fox DA; Sarkar S; Abidi SM; Endres J; Piktel J; Haqqi TM; Singer NG
    J Immunol; 2004 Nov; 173(10):6125-33. PubMed ID: 15528349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
    Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
    J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.